Ann C. Collier
Active 1984–2024
- 113
- Papers
- 24,079
- Citations
- 82
- h-index
- 113
- i10-index
Citations
Citation sources
Countries
Institutions
Fields
- Medicine49.5%
- Immunology and Microbiology40.7%
- Biochemistry, Genetics and Molecular Biology3.1%
- Neuroscience1.7%
- Psychology1.1%
- Mathematics0.9%
- Other3%
Topics
- HIV Research and Treatment19.7%
- HIV/AIDS Research and Interventions13.6%
- HIV/AIDS drug development and treatment10%
- HIV-related health complications and treatments7.8%
- Immune Cell Function and Interaction2.1%
- Cytomegalovirus and herpesvirus research1.9%
- Other44.9%
Coauthors
- David B. Clifford26
- Benjamin B. Gelman24
- Ronald J. Ellis24
- Igor Grant23
- Christina M. Marra22
- Robert K. Heaton22
- Scott Letendre21
- Susan Morgello21
- David M. Simpson20
- J. Allen McCutchan20
- Donald Franklin17
- Justin C. McArthur17
- Lawrence Corey17
- Robert W. Coombs16
- Ronald J. Bosch16
- Margaret A. Fischl14
- Joseph J. Eron13
- Christine Fennema‐Notestine10
- John W. Mellors10
- Ned Sacktor10
- Constance A. Benson9
- J. Hampton Atkinson9
- Catherine Godfrey8
- Douglas D. Richman8
All papers
- HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy
Authors: Robert K. Heaton, David B. Clifford, Donald Franklin, Steven Paul Woods, Christopher F. Ake, Florin Vaida, Ronald J. Ellis, Scott Letendre, Thomas D. Marcotte, J. Hampton Atkinson, Mónica Rivera Mindt, Ofilio Vigil, Michael Taylor, Ann C. Collier, Christina M. Marra, Benjamin B. Gelman, Justin C. McArthur, Susan Morgello, David M. Simpson, J. Allen McCutchan, Ian Abramson, Anthony Gamst, Christine Fennema‐Notestine, Terry L. Jernigan, J. Wong, Igor Grant, For the CHARTER Group - Neurology 2010 cited by 2,318
- Efficacy of a Clinical Decision Rule to Enable Direct Oral Challenge in Patients With Low-Risk Penicillin Allergy
Authors: Ana Maria Copaescu, Sara Vogrin, Fiona James, Kyra Chua, Morgan Rose, Joseph De Luca, Jamie Waldron, Andrew Awad, Jack Godsell, Elise Mitri, Belinda Lambros, Abby Douglas, Rabea Khoudja, Ghislaine Annie Clarisse Isabwe, Geneviève Genest, Michael Fein, Cristine Radojicic, Ann C. Collier, Patricia Lugar, Cosby A. Stone, Moshe Ben‐Shoshan, Nicholas Turner, Natasha E. Holmes, Elizabeth J. Phillips, Jason A. Trubiano - JAMA Internal Medicine 2023 cited by 186
- HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors
Authors: for the CHARTER and HNRC Groups, Robert K. Heaton, Donald Franklin, Ronald J. Ellis, J. Allen McCutchan, Scott Letendre, Shannon LeBlanc, Stephanie Corkran, Nichole A. Duarte, David B. Clifford, Steven Paul Woods, Ann C. Collier, Christina M. Marra, Susan Morgello, Mónica Rivera Mindt, Michael Taylor, Thomas D. Marcotte, J. Hampton Atkinson, Tanya Wolfson, Benjamin B. Gelman, Justin C. McArthur, David M. Simpson, Ian Abramson, Anthony Gamst, Christine Fennema‐Notestine, Terry L. Jernigan, Joseph K. Wong, Igor Grant - Journal of NeuroVirology 2010 cited by 1,550
- The Control of HIV After Antiretroviral Medication Pause (CHAMP) Study: Posttreatment Controllers Identified From 14 Clinical Studies
Authors: Golnaz Namazi, Jesse Fajnzylber, Evgenia Aga, Ronald J. Bosch, Edward P. Acosta, Radwa Sharaf, Wendy Hartogensis, Jeffrey M. Jacobson, Elizabeth Connick, Paul A. Volberding, Daniel J. Skiest, David M. Margolis, Michael C. Sneller, Susan J. Little, Sara Gianella, Davey M. Smith, Daniel R. Kuritzkes, Roy M. Gulick, John W. Mellors, Vikram Mehraj, Rajesh T. Gandhi, Ronald T. Mitsuyasu, Robert T. Schooley, Keith Henry, Pablo Tebas, Steven G. Deeks, Tae‐Wook Chun, Ann C. Collier, Jean‐Pierre Routy, Frederick Hecht, Bruce D. Walker, Jonathan Z. Li - The Journal of Infectious Diseases 2018 cited by 205
- Selective Decay of Intact HIV-1 Proviral DNA on Antiretroviral Therapy
Authors: Rajesh T. Gandhi, Joshua C. Cyktor, Ronald J. Bosch, Hanna Mar, Gregory M. Laird, Albine Martin, Ann C. Collier, Sharon A. Riddler, Bernard Macatangay, Charles R. Rinaldo, Joseph J. Eron, Janet D. Siliciano, Deborah K. McMahon, John W. Mellors, Evelyn Hogg, Rebecca LeBlanc, Christine Scello, David Palm, Monica Gandhi, Courtney V. Fletcher, Anthony T. Podany, Fran Aweeka, Lou Halvas, Joan Dragavon, Jeymohan Joseph, Rose Lagattuta, Leyi Lin, Susan Pederson, Kevin A. Robertson, Leah H. Rubin, Davey M. Smith, Serena Spudich, Athe Tsibris - The Journal of Infectious Diseases 2020 cited by 148
- Neurocognitive Change in the Era of HIV Combination Antiretroviral Therapy: The Longitudinal CHARTER Study
Authors: Robert K. Heaton, Donald Franklin, R Deutsch, Scott Letendre, Ronald J. Ellis, Kaitlin B. Casaletto, María J. Marquine, Steven Paul Woods, Florin Vaida, J. Hampton Atkinson, Thomas D. Marcotte, T. D. Marcotte, Ann C. Collier, Christina M. Marra, David B. Clifford, Benjamin B. Gelman, Ned Sacktor, Susan Morgello, David M. Simpson, Ian Abramson, Anthony Gamst, Christine Fennema‐Notestine, Davey M. Smith, Igor Grant, I. Grant, Igor Grant, I. Grant, J. A. McCutchan, Thomas D. Marcotte, Donald Franklin, D. Franklin, R. J. Ellis, Thomas S. Alexander, T. Alexander, Edmund V. Capparelli, Robert K. Heaton, J. Hampton Atkinson, R. K. Heaton, Mark A. Dawson, Davey M. Smith, Christine Fennema‐Notestine, Michael Taylor, Rebecca J. Theilmann, Anthony Gamst, Clint Cushman, Ian Abramson, Florin Vaida, Thomas D. Marcotte, J. Marquie-Beck, J. McArthur, V. Rogalski, Susan Morgello, David M. Simpson, Letty Mintz, D. Simpson, Will Toperoff, Ann C. Collier, Christina M. Marra, Timothy A. Jones, Benjamin B. Gelman, Eleanor Head, David B. Clifford, M. Al-Lozi, D. Clifford, M. Al-Lozi, Mahlet Belachew - Clinical Infectious Diseases 2014 cited by 408
- Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline
Authors: Igor Grant, Donald Franklin, Reena Deutsch, Steven Paul Woods, Florin Vaida, Ronald J. Ellis, Scott Letendre, Thomas D. Marcotte, J. H. Atkinson, Ann C. Collier, Christina M. Marra, David B. Clifford, Benjamin B. Gelman, Justin C. McArthur, Susan Morgello, David M. Simpson, J. Allen McCutchan, Ian Abramson, Anthony Gamst, Christine Fennema‐Notestine, Davey M. Smith, Robert K. Heaton, For the CHARTER Group - Neurology 2014 cited by 308
- Rebound of plasma viremia following cessation of antiretroviral therapy despite profoundly low levels of HIV reservoir: implications for eradication
Authors: Tae Wook Chun, J. Shawn Justement, Danielle Murray, Claire W. Hallahan, Janine Maenza, Ann C. Collier, Prameet M. Sheth, Rupert Kaul, Mario Ostrowski, Susan Moir, Colin Kovacs, Anthony S. Fauci - AIDS 2010 cited by 288
- White matter damage, neuroinflammation, and neuronal integrity in HAND
Authors: for the CHARTER Group, Aljoharah Alakkas, Ronald J. Ellis, Caitlin Wei‐Ming Watson, Anya Umlauf, Robert K. Heaton, Scott Letendre, Ann C. Collier, Christina M. Marra, David B. Clifford, Benjamin B. Gelman, Ned Sacktor, Susan Morgello, David M. Simpson, J. Allen McCutchan, Asha Kallianpur, Sara Gianella, Thomas D. Marcotte, Igor Grant, Christine Fennema‐Notestine - Journal of NeuroVirology 2018 cited by 109
- Heavy Cannabis Use Associated With Reduction in Activated and Inflammatory Immune Cell Frequencies in Antiretroviral Therapy–Treated Human Immunodeficiency Virus–Infected Individuals
Authors: Jennifer A. Manuzak, Toni Gott, Jay S. Kirkwood, Ernesto Coronado, Tiffany Hensley‐McBain, Charlene Miller, Ryan K. Cheu, Ann C. Collier, Nicholas Funderburg, Jeffery N Martin, Michael C. Wu, Nina Isoherranen, Peter W. Hunt, Nichole R. Klatt - Clinical Infectious Diseases 2017 cited by 115
- Long-Acting Injectable Antiretroviral Treatment Acceptability and Preferences: A Qualitative Study Among US Providers, Adults Living with HIV, and Parents of Youth Living with HIV
Authors: Jane M. Simoni, Kristin Beima‐Sofie, Zahra H. Mohamed, Joan Christodoulou, Kenneth Tapia, Susan M. Graham, Rodney J. Y. Ho, Ann C. Collier - AIDS Patient Care and STDs 2019 cited by 83
- Invasion of the Central Nervous System by Treponema pallidum: Implications for Diagnosis and Treatment
Authors: Sheila A. Lukehart, Edward W. Hook, S A Baker-Zander, Ann C. Collier, Cathy W. Critchlow, H. Hunter Handsfield - Annals of Internal Medicine 1988 cited by 602
- Safety, Pharmacokinetics, and Antiviral Activity of AMD3100, a Selective CXCR4 Receptor Inhibitor, in HIV-1 Infection
Authors: Craig W. Hendrix, Ann C. Collier, Michael M. Lederman, Dominique Schols, Richard B. Pollard, Stephen Brown, J. Brooks Jackson, Robert W. Coombs, Marshall J. Glesby, Charles Flexner, Gary Bridger, Karin Badel, R. T. MacFarland, Geoffrey Henson, Gary Calandra - JAIDS Journal of Acquired Immune Deficiency Syndromes 2004 cited by 362
- Defining Neurocognitive Impairment in HIV: Deficit Scores Versus Clinical Ratings
Authors: Kaitlin Blackstone, David J. Moore, Donald Franklin, David B. Clifford, Ann C. Collier, Christina M. Marra, Benjamin B. Gelman, Justin C. McArthur, Susan Morgello, David M. Simpson, Ronald J. Ellis, J. H. Atkinson, Igor Grant, Robert K. Heaton - The Clinical Neuropsychologist 2012 cited by 240
- Treatment of Human Immunodeficiency Virus Infection with Saquinavir, Zidovudine, and Zalcitabine
Authors: Ann C. Collier, Robert W. Coombs, David Schoenfeld, Roland L. Bassett, Joseph Timpone, Alice Baruch, Michelle Jones, Karen Facey, Caroline C. Whitacre, Vincent McAuliffe, Harvey M. Friedman, Thomas C. Merigan, Richard C. Reichman, Carol J. Hooper, Lawrence Corey - New England Journal of Medicine 1996 cited by 756
- Protective HIV-specific CD8+ T cells evade Treg cell suppression
Authors: Shokrollah Elahi, Warren L. Dinges, Nicholas Lejarcegui, Kerry J. Laing, Ann C. Collier, David M. Koelle, M. Juliana McElrath, Helen Horton - Nature Medicine 2011 cited by 214
- Levels of HIV-1 persistence on antiretroviral therapy are not associated with markers of inflammation or activation
Authors: Rajesh T. Gandhi, Deborah K. McMahon, Ronald J. Bosch, Christina M. Lalama, Joshua C. Cyktor, Bernard Macatangay, Charles R. Rinaldo, Sharon A. Riddler, Evelyn Hogg, Catherine Godfrey, Ann C. Collier, Joseph J. Eron, John W. Mellors, ACTG A5321 Team - PLoS Pathogens 2017 cited by 185
- Persistent HIV-infected cells in cerebrospinal fluid are associated with poorer neurocognitive performance
Authors: Serena Spudich, Kevin R. Robertson, Ronald J. Bosch, Rajesh T. Gandhi, Joshua C. Cyktor, Hanna Mar, Bernard Macatangay, Christina M. Lalama, Charles R. Rinaldo, Ann C. Collier, Catherine Godfrey, Joseph J. Eron, Deborah K. McMahon, Jana L. Jacobs, Dianna Koontz, Evelyn Hogg, Alyssa Vecchio, John W. Mellors - Journal of Clinical Investigation 2019 cited by 121
- Brief Report: Weight Gain Following ART Initiation in ART-Naïve People Living With HIV in the Current Treatment Era
Authors: Stephanie A. Ruderman, Heidi M. Crane, Robin M. Nance, Bridget M. Whitney, Barbara N Harding, Kenneth H. Mayer, Richard D. Moore, Joseph J. Eron, Elvin Geng, William C. Mathews, Benigno Rodríguez, Amanda L. Willig, Greer Burkholder, Sara Lindström, Brian R. Wood, Ann C. Collier, Vani Vannappagari, Cassidy Henegar, Jean van Wyk, Lloyd Curtis, Michael S. Saag, Mari M. Kitahata, Joseph A. Delaney - JAIDS Journal of Acquired Immune Deficiency Syndromes 2020 cited by 81
- U.S. patient preferences for long‐acting HIV treatment: a discrete choice experiment
Authors: Susan M. Graham, Douglas Barthold, Brett Hauber, Aaron T. Brah, Enrique M. Saldarriaga, Ann C. Collier, Rodney J. Y. Ho, the Emory PREFER Team, Vincent C. Marconi, Jane M. Simoni - Journal of the International AIDS Society 2023 cited by 28
- The prevalence and incidence of neurocognitive impairment in the HAART era
Authors: Kevin R. Robertson, Marlene Smurzynski, Thomas D. Parsons, Kunling Wu, Ronald J. Bosch, Julia Wu, Justin C. McArthur, Ann C. Collier, Scott Evans, Ronald J. Ellis - AIDS 2007 cited by 625
- CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy
Authors: Ronald J. Ellis, Jayraan Badiee, Florin Vaida, Scott Letendre, Robert K. Heaton, David B. Clifford, Ann C. Collier, Benjamin B. Gelman, Justin C. McArthur, Susan Morgello, J. Allen McCutchan, Igor Grant - AIDS 2011 cited by 414
- Cells producing residual viremia during antiretroviral treatment appear to contribute to rebound viremia following interruption of treatment
Authors: Hadega Aamer, Jan McClure, Daisy Ko, Janine Maenza, Ann C. Collier, Robert W. Coombs, James I. Mullins, Lisa M. Frenkel - PLoS Pathogens 2020 cited by 40
- Varied Patterns of Decay of Intact Human Immunodeficiency Virus Type 1 Proviruses Over 2 Decades of Antiretroviral Therapy
Authors: Rajesh T. Gandhi, Ronald J. Bosch, Hanna Mar, Gregory M. Laird, Elias K. Halvas, Laura Hovind, Ann C. Collier, Sharon A. Riddler, Albine Martin, Kristen D. Ritter, Deborah K. McMahon, Joseph J. Eron, Joshua C. Cyktor, John W. Mellors, Evelyn Hogg, Rebecca LeBlanc, Christine Scello, David Palm, Monica Gandhi, Courtney V. Fletcher, Anthony T. Podany, Fran Aweeka, Jeymohan Joseph, Susan Pederson, Leah H. Rubin, Davey M. Smith, Serena Spudich, Athe Tsibris - The Journal of Infectious Diseases 2023 cited by 31
